Pfizer Inc. (PFE) 의 후행 P/E는 20.1, 선행 P/E 9.2. 후행 이익수익률은 4.99%, 선행 이익수익률 10.89%. PEG 0.08 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $21.67.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 65/100 3/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2016 | 26.0 | 5.61 | 3.15 | 3.55 | 3.90% |
| 2017 | 9.6 | 0.05 | 2.87 | 3.90 | 3.74% |
| 2018 | 21.8 | -0.47 | 3.83 | 4.53 | 3.28% |
| 2019 | 12.7 | 0.24 | 3.28 | 5.02 | 3.89% |
| 2020 | 22.3 | -0.51 | 3.23 | 4.91 | 4.13% |
| 2021 | 14.9 | 0.11 | 4.28 | 4.07 | 2.64% |
| 2022 | 9.2 | 0.22 | 3.00 | 2.86 | 3.13% |
| 2023 | 76.2 | -0.82 | 1.83 | 2.73 | 5.69% |
| 2024 | 18.7 | 0.07 | 1.70 | 2.36 | 6.33% |
| 2025 | 18.2 | -4.31 | 1.64 | 2.26 | 6.91% |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $1.17 | $52.82B | $7.22B | 13.7% |
| 2017 | $3.52 | $52.55B | $21.31B | 40.6% |
| 2018 | $1.87 | $53.65B | $11.15B | 20.8% |
| 2019 | $2.87 | $51.75B | $16.27B | 31.4% |
| 2020 | $1.25 | $41.91B | $7.02B | 16.8% |
| 2021 | $3.88 | $81.29B | $21.98B | 27% |
| 2022 | $5.47 | $100.33B | $31.37B | 31.3% |
| 2023 | $0.37 | $58.5B | $2.12B | 3.6% |
| 2024 | $1.41 | $63.63B | $8.03B | 12.6% |
| 2025 | $1.36 | $62.58B | $7.77B | 12.4% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $2.96 | $2.87 – $3.06 | $61.19B | $60.32B – $62.09B | 15 |
| 2027 | $2.82 | $2.64 – $2.95 | $58.86B | $56.86B – $60.73B | 15 |
| 2028 | $2.45 | $1.61 – $2.90 | $54.76B | $54.62B – $54.91B | 8 |
| 2029 | $2.17 | $2.10 – $2.25 | $51.66B | $50.3B – $53.11B | 6 |
| 2030 | $2.22 | $2.14 – $2.30 | $51.8B | $50.42B – $53.25B | 6 |
